Level 5, 75 Talavera Road
Macquarie Park , NSW 2109
Translating applied research into actionable outcomes
Research from the Macquarie University Centre for the Health Economy (MUCHE) impacts Australian health policy by enabling decision-makers with independent and qualified information.
Our main objective is to provide government and non-government organisations with world-leading independent and applied research, which can be used to:
- inform public debate
- assist decision making
- help formulate strategy and policy.
Read more about our six key research streams and projects.
Aged care
The aged care research stream explores ways to improve aged care policy and regulation in relation to quality of care, demand, supply and pricing. This includes the use of:
- sophisticated econometric techniques to measure the impact of policy change on the market
- stated preference techniques to explore how older Australians and their carers make choices, including measuring which service attributes are valued most.
Stream leader: Professor Henry Cutler
Team members
Health preferences
The health preference research stream studies how patients, providers, and policymakers make decisions and what shapes their choices. Using tools like Discrete Choice Experiments (DCEs), this research stream examines:
- why people choose specific treatments
- how they use healthcare services
- what healthcare providers and policymakers prioritise.
The goal is to improve health outcomes by developing strategies that make healthcare more effective, accessible, equitable, and valuable.
Stream leader: Associate Professor Yuanyuan Gu
Team members
- Developing a Comprehensive Care Pathway For those at Risk of Suicide But Not in Care: The Under the Radar Project - MRFF Million Minds Mission Suicide Prevention
- EPSP - Patient Preferences for Knee Replacement Surgery in Australia: A Discrete Choice Experiment
- EQ-5D with the hearing “bolt-on” items: developing a new quality of life measure for hearing impairment
- Harnessing implementation science, complexity science and evidence-based care to Keep Australians Out of Hospital: leveraging seven natural experiments in New South Wales
- Home hearing and vision care to improve quality of life for people with dementia and carers
- Implementation and scale-up of a consumer co-designed physical activity promotion program for people with moderate-to-profound disabilities
- Using AI to create smarter, personalised and scalable interventions for pyschological distress
Health technology assessment
Health technology assessment (HTA) is the systematic evaluation of the evidence regarding the health and economic impact of health interventions. HTA aims to maximise population health given resource constraints by synthesising evidence, sometimes using economic model, in a form that can be used by policy makers to decide whether a health intervention is value for money.
Within this stream, we:
- undertake collaborative, multidisciplinary projects with the Australian Government, healthcare organisations and leading researchers
- conduct economic evaluations for a broad range of conditions and health technologies, including medicines, diagnostics, medical devices, and digital technologies
- advise on trial design and conduct within-trial analysis, economic modelling, and analysis of linked healthcare administrative data
- conduct research into HTA methodology and policy in Australia and internationally.
Stream leader: Associate Professor Bonny Parkinson
Team members
- An Evaluation of full scope of Practice Physiotherapy-Led Assessment and Management of Paediatric Orthopaedic Variants
- Australian hitech manufacturer takes-on prostate cancer
- BUBs Quit study: Clinical Midwife Specialist to assist pregnant women to quit smoking using counselling and embedded technology
- Building on newborn hearing screening success: towards national standards and data management
- Embedding Genomics in Primary Care: Using Implementation Science to Design a Robust National Approach
- EQ-5D with the hearing “bolt-on” items: developing a new quality of life measure for hearing impairment
- Hide and seek with hereditary cancer: Improving detection of colorectal cancer patients with a high risk of Lynch syndrome
- Leveraging informatics to optimise pharmacist-led medication reviews in residential aged care to improve outcomes and cost-effectiveness: a pragmatic cluster randomised controlled trial
- Longitudinal outcomes of hearing-impaired children: early vs later intervention
- MRFF - A Pragmatic Randomized Controlled Trial to Digitally Support Self-Management for Inhaler Device Technique and Medication Adherence among People with Chronic Obstructive Pulmonary Disease (COPD) and Comorbidities - The PRISIMA-PECO Trial
- Optimising treatments in mental health using AI
- P-OMICs-flow: Integrating precision oncology into clinical programs
- Randomised controlled trial of screening patients with Schizophrenia for obstructive sleep apnea using in-laboratory polysomnography or 3-nights of home oximetry
- SENSEcog aged care: Hearing and vision support to improve quality of life for people living with dementia receiving aged care services
- Targeted, Adaptive Genomics for Ethical, Evidence-based Expansion of Newborn Screening: a type II hybrid effectiveness-implementation trial
- Translating Evidence-Based Psychological Interventions for Older Adults with Depression and Anxiety into Public and Private Mental Health Settings Using a Stepped Care FrameworkHide and seek with hereditary cancer: Improving detection of colorectal cancer patients with a high risk of Lynch syndrome
Integrated care
This research stream explores ways to facilitate care being delivered through multidisciplinary teams within the healthcare system and across other sectors that impact health outcomes, including:
- education
- housing
- justice.
We evaluate integrated care models for their effectiveness and value, and investigate new ways of funding healthcare to contribute towards funding reform discussions. This research assists the government as they look for ways to extract more value from healthcare spending and better remunerate clinicians and healthcare teams.
Stream leader: Professor Henry Cutler
Team members
- An Evaluation of full scope of Practice Physiotherapy-Led Assessment and Management of Paediatric Orthopaedic Variants
- A Pragmatic Randomized Controlled Trial to Digitally Support Self-Management for Inhaler Device Technique and Medication Adherence among People with Chronic Obstructive Pulmonary Disease (COPD) and Comorbidities - The PRISIMA-PECO Trial
- Implementation and scale-up of a consumer co-designed physical activity promotion program for people with moderate-to-profound disabilities
- National Injury Surveillance for Actionable Research - Emergency Department
- Using AI to create smarter, personalised, and scalable interventions for psychological distress
- Work in heat and health - a toolbox for occupational studies in manual workers in LMIC countries
Mental health
Research in the stream uses a range of quantitative methods to analyse clinical, administrative, experimental, and observational data to understand the determinants of mental health. We:
- investigate how mental healthcare can be provided equitably and efficiently through new models of care, treatments, and funding systems
- study conceptual problems of particular importance in mental health, such as dealing with diagnostic and treatment uncertainty, social spillovers, and the effect of mental health on productivity.
Its goal is to help define policies that improve mental health and economic outcomes.
Stream leader: Associate Professor Jonas Fooken
Team members
- An economic evaluation of LifeSpan
- CORE-DEP: Centre of Research Excellence in Depression Treatment Precision
- Developing a Comprehensive Care Pathway For those at Risk of Suicide But Not in Care: The Under the Radar Project - MRFF Million Minds Mission Suicide Prevention
- Translating Evidence-Based Psychological Interventions for Older Adults with Depression and Anxiety into Public and Private Mental Health Settings Using a Stepped Care Framework
- Optimising treatments in mental health using AI
- Using AI to create smarter, personalised, and scalable interventions for psychological distress
Evaluations
All new pharmaceuticals and vaccines in Australia are evaluated by the Pharmaceutical Benefits Advisory Committee (PBAC). The Macquarie University Evaluation Team is one of only eight university groups in Australia entrusted by the federal Department of Health to advise the PBAC. We consider the safety, clinical effectiveness and cost-effectiveness of the treatments.
The Medical Services Advisory Committee (MSAC) assesses medical services for funding through the Medicare Benefits Schedule. MSAC assesses applications for public funding of health services and technologies, such as diagnostic tests, and advises the federal health minister on which ones are effective and value for money. Macquarie University Evaluation Team also does work for MSAC.
Stream leader: Professor Martin Hoyle
Team members
- Bovine bio inductive collagen implant (REGENETENTM) for the repair of rotator cuff tear - MSAC 1593
- External evaluation of pharmaceutical benefits advisory committee (PBAC) and health technology related submissions
- MSAC PICO - 1760 DPYD genotyping to predict fluoropyrimidine-induced toxicity
- MSAC DCAR-1710 Newborn bloodspot screening for X-linked adrenoleukodystrophy
- PICO 1674 Dostarlimab in mismatch repair deficient (dMMR) recurrent or advanced endometrial cancer
- PICO Confirmation for MSAC 1629 - DAC 5ml Kit
- PICO Confirmation for HPP200250 - Liquid biopsy in patients with non-small cell lung carcinoma
- PICO Confirmation for MSAC application 1597 - Cryoablation for small renal mass
- PICO for MSAC application 1600 - Genetic testing for inherited kidney disease (other than Alport syndrome)
- PICO for MSAC application 1617 - BRAF V600 mutation testing